{"id":"W4407296520","doi":"10.1158/2767-9764.crc-24-0407","title":"Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bayer","keywords":"Nivolumab; Medicine; Tolerability; Adverse effect; Oncology; Internal medicine; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006898667,0.00009516373,0.0002902941,0.0004316943,0.0001377177,0.00001447707,0.0003011946,0.0000317445,0.00001692664],"category_scores_gemma":[0.0001116248,0.0000770924,0.00001592702,0.001606088,0.0004837653,0.0001059102,0.0001449077,0.0004051724,3.139885e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004518909,"about_ca_system_score_gemma":0.0005991712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002018167,"about_ca_topic_score_gemma":0.007643855,"domain_scores_codex":[0.9985916,0.0002971826,0.0003453454,0.0002048045,0.0003487415,0.0002123141],"domain_scores_gemma":[0.9981881,0.0003107149,0.00007798345,0.0009464126,0.0004295022,0.00004731072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03964227,0.009688966,0.8305689,0.0001276425,0.0001733412,0.000003758913,0.003178342,0.00003672153,0.0007039428,0.0002723532,0.0000828999,0.1155209],"study_design_scores_gemma":[0.05366983,0.003114439,0.9391959,0.001183841,0.00002100194,3.492202e-7,0.001615061,0.0002017966,0.0001844626,0.00001926845,0.0007162889,0.00007780995],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931879,0.002371415,0.0000152097,0.001337099,0.000009837899,0.002370706,0.00002017204,0.0000115237,0.0006761522],"genre_scores_gemma":[0.9977062,0.001595236,0.0001742772,0.00004135142,0.000002055643,0.0003294157,0.0000448049,0.00001216396,0.00009449316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1154431,"threshold_uncertainty_score":0.4265451,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04313230397912114,"score_gpt":0.439449919810687,"score_spread":0.3963176158315659,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}